1. Home
  2. WLDS vs EVOK Comparison

WLDS vs EVOK Comparison

Compare WLDS & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

HOLD

Current Price

$1.45

Market Cap

19.7M

ML Signal

HOLD

Logo Evoke Pharma Inc.

EVOK

Evoke Pharma Inc.

HOLD

Current Price

$10.99

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDS
EVOK
Founded
2014
2007
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
18.4M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
WLDS
EVOK
Price
$1.45
$10.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
239.4K
30.8K
Earning Date
12-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,000.00
$14,424,652.00
Revenue This Year
N/A
$58.96
Revenue Next Year
N/A
$57.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
67.40
52 Week Low
$1.00
$1.94
52 Week High
$11.40
$11.00

Technical Indicators

Market Signals
Indicator
WLDS
EVOK
Relative Strength Index (RSI) 31.38 85.30
Support Level $1.83 $10.66
Resistance Level $1.60 $10.99
Average True Range (ATR) 0.12 0.04
MACD -0.00 -0.18
Stochastic Oscillator 5.38 100.00

Price Performance

Historical Comparison
WLDS
EVOK

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: